Neurocognitive profile in a case of maple syrup urine disease.

scientific article published on 2 March 2010

Neurocognitive profile in a case of maple syrup urine disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/13854040903527279
P698PubMed publication ID20204917

P50authorKarin S WalshQ48248847
P2093author name stringMegan N Scott
P2860cites workThe cognitive outcome of hemispherectomy in 71 childrenQ28249231
Intrahippocampal administration of the alpha-keto acids accumulating in maple syrup urine disease provokes learning deficits in ratsQ44728510
Leucine toxicity in a neuronal cell model with inhibited branched chain amino acid catabolism.Q44792673
Developmental profile of patients with maple syrup urine diseaseQ45921973
Impact of longitudinal plasma leucine levels on the intellectual outcome in patients with classic MSUD.Q46835000
Chronic early leucine administration induces behavioral deficits in ratsQ48124557
2-[fluorine-18] fluoro-2-deoxy-D-glucose PET scan of the brain in maple syrup urine diseaseQ48142219
Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescenceQ48395858
Assessing children's memory productions of the Rey-Osterrieth Complex Figure.Q52137027
Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency.Q52163408
Intellectual outcome in children with maple syrup urine disease.Q52236268
P433issue4
P304page(s)689-700
P577publication date2010-03-02
P1433published inNeuropsychology, Development and Cognition. Section D: The Clinical NeuropsychologistQ15749518
P1476titleNeurocognitive profile in a case of maple syrup urine disease.
P478volume24

Reverse relations

cites work (P2860)
Q33617530Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease
Q36548413Developmental Defects of Caenorhabditis elegans Lacking Branched-chain α-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency
Q40300205Intracerebroventricular administration of α-ketoisocaproic acid decreases brain-derived neurotrophic factor and nerve growth factor levels in brain of young rats
Q48002467Maple syrup urine disease (MSUD): a case with long-term follow-up after liver transplantation
Q38890001Neurocognitive profiles in MSUD school-age patients.
Q36703069Neuropsychiatric Symptoms in Inborn Errors of Metabolism: Incorporation of Genomic and Metabolomic Analysis into Therapeutics and Prevention
Q39359596Serum Markers of Neurodegeneration in Maple Syrup Urine Disease
Q34765899The human postsynaptic density shares conserved elements with proteomes of unicellular eukaryotes and prokaryotes
Q38108763The neuropsychiatry of inborn errors of metabolism

Search more.